ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 0464 • ACR Convergence 2024

    Increases in Paraoxonase-1 Activity over Time Associates with Reduced Risk of Incident Inflammatory Arthritis in an Anti-Citrullinated Protein Antibody-Positive Population

    Amir Razmjou1, Rong Guo2, David Elashoff3, Kevin Deane4, Jill Norris5, Marie Feser6, Jennifer Wang1, Ani Shahbazian2 and christina Charles-Schoeman7, 1UCLA, Los Angeles, CA, 2UCLA, Los Angeles, 3UCLA Department of Medicine Statistics Core, Los Angeles, 4University of Colorado Denver Anschutz Medical Campus, Aurora, CO, 5Colorado School of Public Health, Denver, CO, 6Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 7UCLA Medical Center, Santa Monica, CA

    Background/Purpose: Rheumatoid arthritis (RA) has a well described pre-clinical state, with a continuum of genetic and environmental risk factors leading to the development of systemic…
  • Abstract Number: 0442 • ACR Convergence 2024

    Anti-U1-RNP Related Pregnancy Loss in Systemic Lupus Erythematosus

    Anam Nazir1, Joshua Reed2, Khalid Alghamdi2 and Catherine Ivory1, 1The Ottawa Hospital, Ottawa, ON, Canada, 2The Ottawa Hospital Research Institute, Ottawa, ON, Canada

    Background/Purpose: Systemic lupus erythematosus (SLE) affects women of childbearing years and confers an increased risk of pregnancy complications. Risk of adverse events in pregnancy is…
  • Abstract Number: 0410 • ACR Convergence 2024

    Efficacy of Modified Dosing/interval Timing of Adalimumab in Patients Affected by Chronic Non Infectious Uveitis: A Retrospective Monocentric Study

    Melissa Lerman1, Devlin Eckardt1 and Sabino Germinario2, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2Università degli studi di Milano, Milan, Italy

    Background/Purpose: Non-infectious uveitis (NIU), inflammation of the eye, can occur in isolation, as in idiopathic uveitis (29% of all pediatric diagnosis), but may also be…
  • Abstract Number: 0484 • ACR Convergence 2024

    Cluster Analysis Based on Joint Characteristics: A Study of Joint Involvement Profiles in Early Rheumatoid Arthritis (ERA) Patients in China

    Yafang Deng1, Chen Yu2, Lin Qiao1, Nan Jiang1, Yanhong Wang3, Xinping Tian1, Qian Wang1, Mengtao Li4 and Xiaofeng Zeng1, 1Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 2Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Dong Cheng Qu, China (People's Republic), 3Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 4Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China 2National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China

    Background/Purpose: Rheumatoid Arthritis (RA) is a chronic inflammatory autoimmune disorder characterized by aggressive articular damage, and articular symptoms are often the initial and significant clinical…
  • Abstract Number: 0461 • ACR Convergence 2024

    Complete Description of the Three Pathways of the Complement System in a Series of 430 Patients with Rheumatoid Arthritis

    ivan Ferraz-Amaro1, Maria Garcia-Gonzalez2, Fuensanta Gomez-Bernal3, Juan Carlos Quevedo-Abeledo4 and Miguel Angel Gonzalez-Gay5, 1Rheumatology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Canarias, Spain, 2Hospital Universitario de Canarias, SC Tenerife, Canarias, Spain, 3Hospital Universitario de Canarias, Santa Cruz de Tenerife, Canarias, Spain, 4Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de GC, Canarias, Spain, 5University of Cantabria, Fundación Jimenez Díaz, Madrid, Madrid, Spain

    Background/Purpose: The complement (C) system has been implicated in the etiopathogenesis of rheumatoid arthritis (RA). We aimed to examine the correlation between an in-depth evaluation…
  • Abstract Number: 0232 • ACR Convergence 2024

    Subjective and Objective Measures of Disease Activity in Difficult-to-Treat Rheumatoid Arthritis Patients at Baseline and Follow-up After an Advanced Therapy: An Ultrasound Study

    Seyyid Bilal Acikgoz1, Ricardo Sabido-Sauri2, Ozun Bayindir Tsechelidis3, Ummugulsum Gazel2, Sylvia Sangwa4, Elliot Hepworth2 and Sibel Aydin5, 1University of Ottawa, Rheumatology, Ottawa, ON, Canada, 2University of Ottawa, Ottawa, ON, Canada, 3Ottawa University, Ottawa, ON, Canada, 4The Ottawa Hospital Research Institute, Ottawa, Canada, 5University of Ottawa - Ottawa, Ottawa, ON, Canada

    Background/Purpose: In the era of several advanced therapies and an increasing number of patients with rheumatoid arthritis (RA) who have been failed by multiple therapies,…
  • Abstract Number: 0401 • ACR Convergence 2024

    Biologic Abatement and Capturing Kids Outcomes and Flare Frequency in Juvenile Spondyloarthritis: Baseline Characteristics and Enrollment

    Cora Sears1, Cassandra Muir1, Timothy Brandon1, Polly Ferguson2, Colleen Correll3, Margalit Rosenkranz4, Kevin Baszis5, Tzielan Lee6, Edward Oberle7, Matthew Stoll8, Kathryn Cook9, Eyal Muscal10, Hemalatha Srinivasalu11, Daniel Lovell12, Sampath Prahalad13, Michal Cidon14, Evan Mulvihill15, Marisa Klein-Gitelman16, Daniel Kingsbury17, Jennifer Cooper18, Natalie Rosenwasser19, Erin Treemarcki20, Joyce Chang21, Stacey Tarvin22, Heather Walters23, Michael Shishov24, Lisa Buckley25, Mary Toth26, Ashley Cooper27, Rui Xiao28, Emily Neu29, Melanie Kohlheim30, Jenny Leal31, Kweli Archie32, English Holland33, Miles Holland34, Aamena Hameed35, Asad Khan36, Lynn Murphy37, Sean Murphy38, Justin Neu29, Rachel Richmond39, Dylan Suplee40, Theresa Suplee41, Dawn Wiley42 and Pamela Weiss43, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2University of Iowa Carver College of Medicine, Iowa City, IA, 3University of Minnesota, Minneapolis, MN, 4UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, 5Washington Univ in St. Louis School of Medicine, St Louis, MO, 6Stanford University School of Medicine, Palo Alto, CA, 7Nationwide Children's Hospital, Columbus, OH, 8University of Alabama at Birmingham, Birmingham, AL, 9Akron Children's Hospital, Akron, OH, 10Baylor College of Medicine, Houston, TX, 11Children's National Hospital, Washington, DC, 12Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 13Emory + Children's Pediatric Institute, Atlanta, GA, 14Children's Hospital of Los Angeles, Los Angeles, CA, 15Nemours/A.I.duPont Hospital for Children, Wilmington, DE, 16Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 17Legacy Health, Portland, OR, 18University of Colorado/Children's Hospital Colorado, Aurora, CO, 19Seattle Children's Hospital, Seattle, WA, 20University of Utah, Salt Lake City, UT, 21Boston Children's Hospital, Boston, MA, 22Indiana University School of Medicine, Indianapolis, IN, 23Northwell Health, New Hyde Park, NY, 24Phoenix Children's Hospital, Phoenix, AZ, 25Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN, 26Nemours Foundation, Orlando, FL, 27Children's Mercy Kansas City, Kansas City, MO, 28University of Pennsylvania, Philadelphia, PA, 29Parent Partner, Sidney, OH, 30Parent Partner, Granville, OH, 31Parent Partner, Columbus, OH, 32Parent Partner, Philadelphia, PA, 33Parent Partner, Williamsburg, VA, 34Patient Partner, Williamsburg, VA, 35Parent Partner, Franklin Park, NJ, 36Patient Partner, Franklin Park, NJ, 37Parent Partner, Haddon Heights, NJ, 38Patient Partner, Haddon Heights, NJ, 39Parent Partner, Albuquerque, NM, 40Patient Partner, Maple Shade, NJ, 41Parent Partner, Maple Shade, NJ, 42Parent Partner, Downingtown, PA, 43Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Inactive disease is the goal for youth with spondyloarthritis (SpA).  Many patients are interested in stopping medications after inactive disease is achieved. The risk…
  • Abstract Number: 0478 • ACR Convergence 2024

    Skin Sodium in Patients with Rheumatoid Arthritis: Association with Blood Pressure and Disease Activity

    Carolina Ramirez, Annette Oeser, Rachelle Crescenzi, C. Michael Stein and Michelle Ormseth, Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Sodium is stored in tissues such as the skin where it may contribute to development and progression of autoimmune diseases and hypertension through activation…
  • Abstract Number: 0453 • ACR Convergence 2024

    Risk of Active Disease Determines the Expert Opinion Use of Biologics in Pregnancy, but Less in Breastfeeding, and in Men Planning a Family

    Andrea Pluma1, Linda Rüegg2, Sabrina Hamroun3, Axel Finckh4, Yvette Meissner5 and Frauke Foerger6, 1Vall d'Hebron University Hospital, Barcelona, Spain, 2Inselspital, Bern University Hospital, Bern, Switzerland, 3Cochin University Hospital, Paris, Ile-de-France, France, 4Geneva University Hospital, Geneva, Switzerland, 5Deutsches Rheuma-Forschungszentrum, Berlin, Germany, 6University hospital Bern /Inselspital Bern, Bern, Switzerland

    Background/Purpose: Counselling patients with rheumatic and musculoskeletal diseases (RMD) in the phase of reproduction, pregnancy and breastfeeding is a challenging task. The potential risk of…
  • Abstract Number: 0400 • ACR Convergence 2024

    Osteoclastogenesis from Peripheral Blood Mononuclear Cells in Children with Chronic Nonbacterial Osteomyelitis Are Similar to Those from Healthy Children

    Jacqueline Bui1, Jacob Curry2, Jessica Kent3, Payton Danosky4, Kellen Sanders4, Sriya Paluvayi4, Wendy Garcia4, Alejandra Ruppe4, Megan Cheung4, Anna Saack4, Xinrui Bao4, Audrey Luey4, Michelle Kim4, Emily McDaniel4, Amanda Chiu4, Sophia Ahn5, Ji-Won Park4, Sudheshna Thirunahari4, Cammie Wei4, Liau Adriel5, Sophia Pham4, Sadie Van Den Bogaerde4, Joshua Scheck4, Ian Muse6, Ava Klein5, Xing Wang7, James Cassat8 and Yongdong Zhao6, 1Seattle Children’s Research Institute, University of Washington, Bellevue, WA, 2Seattle Children’s Research Institute, Vanderbilt University Medical Center, Seattle, WA, 3Seattle Children’s Research Institute, Medical College of Wisconsin, Seattle, WA, 4Seattle Children’s Research Institute, University of Washington, Seattle, WA, 5Seattle Children’s Research Institute, University of Washington, Seattle, 6Seattle Children's Research institute, Seattle, WA, 7Biostatistics Epidemiology and Analytics in Research, Seattle Children’s Research Institute, Seattle, WA, 8Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Chronic nonbacterial osteomyelitis (CNO) is an autoinflammatory bone disease in which osteoclastogenesis may play a critical role. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) was shown…
  • Abstract Number: 0390 • ACR Convergence 2024

    Treatment Effectiveness Following Switching from Initial TNF Inhibitor in Juvenile Idiopathic Arthritis

    Mei-Sing Ong1, Sarah Ringold2, Melissa Mannion3, Marc Natter4 and Yukiko Kimura5, 1Harvard Medical School & Harvard Pilgrim Healthcare Institute, Boston, MA, 2Washington University, Seattle, 3University of Alabama at Birmingham, Birmingham, AL, 4Boston Children's Hospital, Boston, MA, 5Hackensack Meridian School of Medicine, New York, NY

    Background/Purpose: Although the increasing availability of biologic therapies has significantly improved outcomes for patients with JIA, a substantial proportion of patients require switching from the…
  • Abstract Number: 0479 • ACR Convergence 2024

    Constructing and Using a Novel Nucleotide Transformer for Patients with Rheumatoid Arthritis

    Shant Ayanian, Collin Osborne, Marc Blasi, Daniel Darveaux, Eric Klee and Elena Myasoedova, Mayo Clinic, Rochester, MN

    Background/Purpose: Applying the methods of artificial intelligence (AI) to genomic data for clinical outcome prediction in rheumatoid arthritis (RA) is an area of growing research.…
  • Abstract Number: 0418 • ACR Convergence 2024

    Improving Documentation of Contraception and Pregnancy Intention in Rheumatology Practice

    Megan Clowse1, Puneet Bajaj2, Bonnie Bermas2, Julie Chiesa3, Kathryn Dao4, Pamela Freeman5, Bansari Gujar6, Brittany Hill7, Kelley Jones8, Richard Jones9, Ann Marslett10, Brooke Mills11, James Roberts2, Amanda Snyderman8 and Leah Zulig12, 1Duke University, Chapel Hill, NC, 2UT Southwestern Medical Center, Dallas, TX, 3InfoDirectors, Durham, NC, 4Rheum101, Rockville, MD, 5Rheumatology Associates of Central Florida, Orlando, FL, 6Rheumatology Associates of Baltimore, Towson, MD, 7Clinic for Rheumatic Disease, Tuscaloosa, AL, 8Duke University School of Medicine, Durham, 9Clinic for Rheumatic Diseases, Northport, AL, 10Rheumatology Associates of Baltimore, Baltimore, MD, 11UT Southwestern Medical Center, Fort Worth, TX, 12Duke University School of Medicine, Durham, NC

    Background/Purpose: Prior studies of RISE Registry found 9-11% of women of reproductive age with contraception documentation.  We sought to identify and assess methods to increase contraception documentation…
  • Abstract Number: 0416 • ACR Convergence 2024

    Proteomic Signatures of Synovial Fluid in Different Subtypes of Juvenile Idiopathic Arthritis

    narendra bagri1, saumya srivastava2, yogendra singh2, Thirumurthy Velpandian2, Ashish Upadhyay2, venkatesan sampath kumar2, Subhradip Karmakar2 and sushil K Kabra2, 1All India Institute of Medical Sciences, New Delhi, Delhi, India, 2AIIMS New Delhi, new delhi, India

    Background/Purpose: Juvenile Idiopathic Arthritis (JIA) is heterogenous group of inflammatory disorder with clinically distinct subtypes; polyarticular, oligoarticular systemic onset JIA (sJIA), and enthesitis-related arthritis (ERA).…
  • Abstract Number: 0429 • ACR Convergence 2024

    Exploring the Impact of Autoimmune Rheumatic Diseases on Human Milk Macronutrient Composition

    Rashmi Dhital1, Kerri Bertrand2, Essi Heinonen3 and Christina Chambers4, 1UC San Diego, Brentwood, TN, 2UC San Diego, San Diego, CA, 3UC San Diego, La Jolla, CA; Karolinska Institutet, Stockholm, Sweden, San Diego, CA, 4University of California, San Diego, La Jolla, CA

    Background/Purpose: Systemic inflammation in autoimmune rheumatic diseases (ARDs) may alter human milk composition, akin to changes observed in other inflammatory states, indirectly impacting infant health,…
  • « Previous Page
  • 1
  • …
  • 336
  • 337
  • 338
  • 339
  • 340
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology